Patent panel reserves move on Novartis plea

 IPAB is hearing Novartis' appeal against the Indian Patent Office decision not to allow patent protection for its anti-cancer drug Glivec in India.

The Swiss pharma major had objected to the composition of the patents cell of IPAB on the grounds that Chandrasekhar was Controller General of Patents when the company